Zhu et al. reported that the protein level of NR4A1 was upregulated in NSCLC tissues compared with matched normal tissues, and elevated NR4A1 expression was correlated with clinical stage and tumor recurrence [41]. The gene discussed is NR4A1; the disease is neoplasm.